TKO Q1 2026 Earnings EPS Misses Estimates Amidst Operational Investments GCI Liberty Inc GLIBA Q1 2026 Earnings Massive EPS Miss Sinks Shares Telomir Pharmaceuticals Q4 2025 Earnings Wider Than Expected Loss Highlights ClinicalStage Challenges SLB Q1 2026 Earnings EPS Misses Estimates by Narrow Margin Despite Stable Revenue IN8bio Q1 2026 Earnings EPS Beat Drives Modest Stock Gain as Development Costs Remain under Control Mesa Laboratories Inc MLAB Q1 2026 Earnings Strong EPS Surprise of 130 Amid Quiet Revenue Disclosure Agree Realty ADC Q1 2026 Earnings EPS Beat Amid Modest Stock Decline CRS Q1 2026 Earnings EPS Beats Estimates by 408 Stock Shows Modest Uptick BLX Q1 2026 Earnings Solid EPS Performance Amid Market Volatility CURR Q3 2025 Earnings Strong EPS Surprise as Profitability Emerges Revenue Details Not Disclosed GSK Q1 2026 Earnings Solid EPS Beat Amid Mixed Market Sentiment GBLI Q1 2026 Earnings Significant EPS Miss Underscores Underwriting Challenges